A detailed history of Private Trust CO Na transactions in United Therapeutics Corp stock. As of the latest transaction made, Private Trust CO Na holds 68 shares of UTHR stock, worth $24,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68
Previous 74 8.11%
Holding current value
$24,980
Previous $23,000 4.35%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $1,866 - $2,181
-6 Reduced 8.11%
68 $24,000
Q1 2024

Apr 24, 2024

BUY
$210.76 - $249.51 $421 - $499
2 Added 2.78%
74 $16,000
Q4 2023

Jan 24, 2024

SELL
$214.88 - $256.94 $429 - $513
-2 Reduced 2.7%
72 $15,000
Q3 2023

Oct 18, 2023

BUY
$211.82 - $248.24 $1,270 - $1,489
6 Added 8.82%
74 $16,000
Q1 2023

Apr 12, 2023

BUY
$212.99 - $276.17 $2,555 - $3,314
12 Added 21.43%
68 $15,000
Q2 2022

Sep 16, 2022

BUY
$174.81 - $241.14 $9,789 - $13,503
56 New
56 $13,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.